Javascript must be enabled for the correct page display

Cost-effectiveness analysis of pembrolizumab as first- or second-line treatment for stage III and IV melanoma in the Netherlands

Quist, Sara (2019) Cost-effectiveness analysis of pembrolizumab as first- or second-line treatment for stage III and IV melanoma in the Netherlands. Bachelor's Project, Pharmacy.

[img] Text
bPHAR_2019_QuistSW.pdf
Restricted to Registered users only

Download (1MB)

Abstract

De begeleider en/of auteur heeft geen toestemming gegeven tot het openbaar maken van de scriptie. The supervisor and/or the author did not authorize public publication of the thesis.

Item Type: Thesis (Bachelor's Project)
Supervisor:
Supervisor nameSupervisor E mail
Postma, M.J.M.J.Postma@rug.nl
Degree programme: Pharmacy
Thesis type: Bachelor's Project
Language: English
Date Deposited: 03 Jul 2019
Last Modified: 03 Jul 2019 11:41
URI: http://fse.studenttheses.ub.rug.nl/id/eprint/19825

Actions (login required)

View Item View Item